Novartis AG NOVN-CH:Swiss Exchange

*Data is delayed | Exchange | CHF
Last | 05/17/24 CEST
93.37UNCH (UNCH)
52 week range
79.21 - 94.52
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close93.37
  • 52 Week High94.52
  • 52 Week High Date01/22/24
  • 52 Week Low79.21
  • 52 Week Low Date07/07/23

Key Stats

  • Market Cap201,629.93M
  • Shares Out1,956.49M
  • 10 Day Average Volume-
  • Dividend3.30
  • Dividend Yield3.53%
  • Beta0.79
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close93.37
  • 52 Week High94.52
  • 52 Week High Date01/22/24
  • 52 Week Low79.21
  • 52 Week Low Date07/07/23
  • Market Cap201,629.93M
  • Shares Out1,956.49M
  • 10 Day Average Volume-
  • Dividend3.30
  • Dividend Yield3.53%
  • Beta0.79
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)6.63
  • P/E (TTM)14.08
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Novartis AG

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided...
Joerg Reinhardt Ph.D.
Independent Non-Executive Chairman of the Board
Vasant Narasimhan M.D.
Chief Executive Officer, Member of the Executive Committee
Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Address
Lichtstrasse 35
Basel
4056
Switzerland